Which statement best reflects vitamin D management in hyperparathyroidism?

Which statement best reflects vitamin D management in hyperparathyroidism?

• A. Vitamin D is never monitored
• B. Vitamin D is routinely monitored and may be supplemented
• C. Vitamin D is contraindicated
• D. Vitamin D should be given only if calcium is low

Answer: (B)

Vitamin D status affects PTH control and bone health in hyperparathyroidism, so it’s important to check and address it. Because deficiency is common and correcting it can help lower PTH and protect bones, vitamin D should be routinely monitored (typically measuring 25-hydroxyvitamin D) and supplemented if deficient, with careful monitoring of calcium and phosphate to avoid hypercalcemia. This makes the statement that vitamin D is routinely monitored and may be supplemented the best fit. It’s not contraindicated, and supplementation isn’t limited to when calcium is low.

Vitamin D status affects PTH control and bone health in hyperparathyroidism, so it’s important to check and address it. Because deficiency is common and correcting it can help lower PTH and protect bones, vitamin D should be routinely monitored (typically measuring 25-hydroxyvitamin D) and supplemented if deficient, with careful monitoring of calcium and phosphate to avoid hypercalcemia. This makes the statement that vitamin D is routinely monitored and may be supplemented the best fit. It’s not contraindicated, and supplementation isn’t limited to when calcium is low.